An Enhanced LC–MS-MS Technique for Distinguishing Δ8- and Δ9-Tetrahydrocannabinol Isomers in Blood and Urine Specimens

Screening and confirmation methods for the qualitative identification of nine phytocannabinoids in urine by LC-MS/MS

(2021) Jami D. Reber et al.   CLINICAL BIOCHEMISTRY

ANSI/ASB Standard 036 for Method Validation in Forensic Toxicology Has Replaced SWGTOX’s Version

(2020) Marc A LeBeau   JOURNAL OF ANALYTICAL TOXICOLOGY

Cannabidiol as the Substrate in Acid-Catalyzed Intramolecular Cyclization

(2020) Paola Marzullo et al.   JOURNAL OF NATURAL PRODUCTS

Cannabidiol Adverse Effects and Toxicity

(2019) Marilyn A. Huestis et al.   Current Neuropharmacology

Cannabinoid Markers in Biological Fluids and Tissues: Revealing Intake

(2018) Marilyn A. Huestis et al.   TRENDS IN MOLECULAR MEDICINE

Cannabis-Impaired Driving: A Public Health and Safety Concern

(2015) M. A. Huestis   CLINICAL CHEMISTRY

Isolation and Pharmacological Evaluation of Minor Cannabinoids from High-Potency Cannabis sativa

(2015) Mohamed M. Radwan et al.   JOURNAL OF NATURAL PRODUCTS

Enhanced Solubility, Stability, and Transcorneal Permeability of Delta-8-Tetrahydrocannabinol in the Presence of Cyclodextrins

(2011) Ketan Hippalgaonkar et al.   AAPS PHARMSCITECH

Do Δ9-tetrahydrocannabinol concentrations indicate recent use in chronic cannabis users?

(2009) Erin L. Karschner et al.   ADDICTION